New York & Tri-State CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
RegenLab Leases Thor Equities’ NJ Life Sciences Property
RegenLab has signed a long-term lease at Thor Equities Group’s new life sciences property in Jersey City, NJ. The regenerative cell therapy device manufacturer will occupy 15,792 square feet on the sixth floor, relocating from Brooklyn in Q2 2024 for office and medical device manufacturing.
Located at 95 Greene St, the eight-story, 350,000-square-foot property was redeveloped by Thor from a manufacturing plant for Colgate Palmolive.
JLL’s Dan Spero, Blake Goodman, John Cahill, Bob Ryan and Craig Eisenhardt served as exclusive agents for 95 Greene St. and represented Thor Equities Group and RegenLab in the lease negotiations. “We are seeing significant activity from companies like RegenLab seeking to relocate from New York to best-in-class properties highly accessible to a skilled labor pool,” said Goodman. “95 Greene offers a powerful destination given its proximity to both NYC and NJ talent with great transit access from both sides.”
- ◦Lease
